Centenara Labs AG
PrivateLast Round
Series B
Sep 11, 2023
Total Funding Raised
$75M
Company Overview
Centenara Labs AG is a biotechnology company that operates an integrated platform to develop therapies and fund startups focused on healthy aging and age-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Centenara Labs AG Comparables
Compare Centenara Labs AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Endogena Therapeutics | 89% | |
| Cambrian Bio | 86% | |
| Juvenescence | 82% |
Centenara Labs AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 11, 2023 |
Centenara Labs AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Catalio Capital Management | Series B |
| Coeli Asset Management | Series A |
| Apeiron Investment Group | Series B |
| Mubadala Capital | Series B |
Centenara Labs AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Centenara Labs AG's valuation, stock price, and market status.
Is Centenara Labs a public or private company?
Centenara Labs is a private company.
What is the current stock price of Centenara Labs?
Centenara Labs is a private company with no public stock price. No recent secondary market data is available.
How much is Centenara Labs worth (valuation)?
Valuation information for Centenara Labs is not publicly available.
Can I buy Centenara Labs stock?
Centenara Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Centenara Labs's last funding round?
Centenara Labs's most recent funding round was Series B on September 11, 2023.
Who are the main investors in Centenara Labs?
Key investors in Centenara Labs include Catalio Capital Management, Apeiron Investment Group.
Will Centenara Labs IPO soon?
No public IPO plans have been announced for Centenara Labs.
How can I track Centenara Labs secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Centenara Labs's secondary market activity and sign up for updates.